Performance and Safety of MiWEndo-assisted Colonoscopy (MiWEndo II)

Performance and Safety of MiWEndo-assisted Colonoscopy: MiWEndo II (Pivotal Study)

The study involves the planned use of a new microwave-based device during colonoscopy procedures in 50 patients to assess the performance and safety of its use for detection of colorectal polyps and lack of normal clinical practice modification. The device is a final design version, which has been previously tested in several preclinical studies (including phantom studies, an ex vivo study with human tissues, and an in vivo study with porcine model) and in a pilot study in humans (NCT05477836)

Study Overview

• Status: Recruiting
• Conditions: Colorectal Neoplasms; Colorectal Cancer; Colorectal Adenoma; Colorectal Adenocarcinoma; Colorectal Polyp; Colorectal Adenomatous Polyp
• Intervention / Treatment: Device: MiWEndo System

Detailed Description

This study is designed as a single-center prospective, non-comparative study in 50 patients, whereby data will be subject to an analytical description, rather than to a statistical treatment (refer to Statistical design and analysis).

In this study the principal aims are to assess the performance and safety of the device for the detection of colorectal polyps when used as an accessory to colonoscopy. Relevant claims to verify in this study are that the device will detect in first instance polyps not detected initially with the endoscopic image and can be used without ADEs, without any change in the current clinical practice, as well as without any major difficulty by the endoscopist, neither in the preparation nor in the use of the device during exploration.

In addition, in the first phase of the study (n=15 patients), the study aims to gather real clinical data with the use of the device to optimise the processing software that will be key to demonstrate MiWEndo's performance on the second part of the study (n=35 patients).

Consequently, principal and secondary objectives of this investigation, are:

Principal objectives:

• To assess the performance of MiWEndo-assisted colonoscopy in the detection of colorectal polyps.
• To assess the safety of MiWEndo-assisted colonoscopy.

Secondary objectives:

• To assess the perception of difficulty by the endoscopist when the device is used.
• To provide exploratory analysis of differences in MiWEndo-assisted colonoscopy in different groups of patients to guide future RCT.
• To assess the patient's comfort.

• Study Type: Interventional
• Enrollment (Estimated): 50
• Phase: Not Applicable

Contacts and Locations

Study Locations

• Spain
  • Barcelona, Spain
    • Recruiting
    • Hospital Clinic
    • Contact: Glòria Fernández; Phone Number: 0034626710677; Email: mgfernan@clinic.cat

Participation Criteria

Eligibility Criteria

• Ages Eligible for Study: Adult; Older Adult
• Accepts Healthy Volunteers: No

Description

Inclusion Criteria:

- Patients with a previously detected polyp in the rectum referred for resection.

These criteria will ensure the probability of finding polyps during the explorations.

All the patients will give written informed consent.

Exclusion Criteria:

• Patients at a high risk of having major complications as perforation or hemorrhage, suspected or proven lower gastrointestinal bleeding, non-correctable coagulopathy or anticoagulant/clopidogrel therapy during procedure, inadequate bowel cleansing.
• ASA-IV patients.
• Urgent colonoscopy.

Study Plan

How is the study designed?

Design Details

• Primary Purpose: Diagnostic
• Allocation: N/A
• Interventional Model: Single Group Assignment
• Masking: None (Open Label)

Number of Arms

1

Arms and Interventions

Participant Group / Arm

Intervention / Treatment

Experimental: MiWEndo + colonoscope; All patients will be explored with MiWEndo as an accessory to colonoscopy

Device: MiWEndo System; All colonoscopies will be performed with high-definition technology. The MiWEndo System will be fitted to the tip of the endoscope before colonoscopy is started and connected to the microwave processor unit. Endoscopies will be performed by experienced endoscopists who will be previously trained on the use of the MiWEndo System. The MiWEndo Analyzer will be managed by the assistant. At the beginning of the extubation, the MiWEndo System will be turned on and the endoscopist will put music headphones on (blind to the results of MiWEndo). In case one of them identifies a polyp, the exploration will be stopped and check if it has been detected by the alternative method as well. All the polyps will be resected and sent to the Pathological Department for histological analysis following the usual clinical practice. A stopwatch will be used to measure both total procedure time and withdrawal time.

What is the study measuring?

Primary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number of polyps	With MiWEndo assisted colonoscopy, detect at least one polyp before colonoscopy in 10% of patients.	During the procedure.
Number of adverse events.	Number of adverse events related with the use of the MiWEndo using the lexicon proposed by the American Society of Gastrointestinal Endoscopy (ASGE) (Cotton PB et al. GIE 2010;71:446-54).	During the procedure and up to 2 weeks after.
Number of mural injuries.	Mural injuries related with the use of the MiWEndo.	During the procedure and up to 2 weeks after.

Secondary Outcome Measures

Outcome Measure	Measure Description	Time Frame
Number and size (adenomas and polyps).	The number and size of all lesions (adenomas and all polyps) detected with MiWEndo-assisted colonoscopy.	During procedure.
True positives (TP), False positives (FP), False negatives (FN).	The concordance with the lesions detected by the standard colonoscopy (TP, FP, FN).	During procedure.
Patients' comfort.	Patients' feedback related to colonoscopy using the Gloucester comfort score that ranges from 1 (no discomfort) to 5 (severe discomfort).	Immediately after the procedure and 2 weeks after.
Perception of difficulty.	Perception of difficulty by the endoscopist based on a 5-points Likert scale (very easy to very difficult or very much to very little).	Immediately after the procedure.

Collaborators and Investigators

• Sponsor: MiWEndo Solutions S.L.

Study record dates

Study Major Dates

• Study Start (Actual): August 1, 2023
• Primary Completion (Estimated): December 29, 2025
• Study Completion (Estimated): December 29, 2025

Study Registration Dates

• First Submitted: August 1, 2023
• First Submitted That Met QC Criteria: August 9, 2023
• First Posted (Actual): August 14, 2023

Study Record Updates

• Last Update Posted (Estimated): September 29, 2025
• Last Update Submitted That Met QC Criteria: September 23, 2025
• Last Verified: September 1, 2025

More Information

Terms related to this study

• Keywords: colonoscopy; colorectal cancer screening; early diagnosis; microwave imaging
• Additional Relevant MeSH Terms: Pathologic Processes; Neoplasms by Site; Neoplasms; Intestinal Diseases; Gastrointestinal Neoplasms; Digestive System Neoplasms; Digestive System Diseases; Gastrointestinal Diseases; Intestinal Neoplasms; Rectal Diseases; Colonic Diseases; Pathological Conditions, Signs and Symptoms; Colorectal Neoplasms; Disease
• Other Study ID Numbers: MW II-CIP

Drug and device information, study documents

• Studies a U.S. FDA-regulated drug product: No
• Studies a U.S. FDA-regulated device product: No
• product manufactured in and exported from the U.S.: No